Where are we going with preimplantation genetic diagnosis?
Timothy Krahn Timothy Krahn is with Novel Tech Ethics, Dalhousie University, Halifax, NS. Correspondence to: Timothy Krahn, Novel Tech Ethics, Intellectual Commons, Dalhousie University, 1234 LeMarchant St., Halifax NS B3H 3P7; fax 902 494-2924; tim.krahn{at}dal.ca’ + u + ‘@’ + d + ”//–> In Canada, preimplantation genetic diagnosis is governed by the Assisted Human Reproduction Act,1 which received royal assent on Mar. 29, 2004. Regulations for preimplantation genetic diagnosis in accordance with the act are currently being developed after a series of ongoing public consultations. To regulate uncertain and controversial public policy issues, such as assisted human reproduction, the Canadian government has an established history of taking its bearings from the best practises, policy precedents and relevant regulatory structures in the United Kingdom.2,3 In light of this history, it is fitting for us to pay attention to recent developments in the United Kingdom. On May 10, 2006, the Un
